RHYTHM PHARMACEUTICALS, INC. (RYTM)

SEC filing

RHYTHM PHARMACEUTICALS, INC.

RYTM · CIK 1649904

4 · Sep 14, 2026 · Director, President and CEO Meeker David P sold 50K shares at $102.67/share ($5.1M); exercised options for 100K shares

Director, President and CEO Meeker David P sold 50K shares at $102.67/share ($5.1M); exercised options for 100K shares

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).